Research Article
Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year
Table 6
Comparison of scores at V1 and V2 in patients reporting improvement or deterioration of IBD symptoms. Effect-size calculated with Cohen’s d.
| | | V1 | V2 | Difference (95% CI) | Cohen’s d | value |
| | Improvement of symptoms mean (SD) | | | | | | | | F1 Impact of disease | 22 | 45.4 (18.9) | 26.6 (17.2) | 18.7 (12.6–24.9) | 1.04 | <0.001 | | F2 Expectancy | 22 | 49.1 (22.6) | 31.2 (24.5) | 17.9 (8.8–27.0) | 0.75 | 0.002 | | F3 Treatment | 22 | 48.4 (24.3) | 23.1 (18.6) | 25.4 (15.0–35.8) | 1.16 | 0.049 | | F4 Intimacy | 22 | 32.5 (25.5) | 18.7 (23.0) | 13.8 (6.1–21.6) | 0.56 | <0.001 | | F5 Stigma | 22 | 34.5 (23.1) | 19.2 (17.9) | 15.3 (6.4–24.2) | 0.74 | 0.009 | | F6 Complications | 22 | 33.9 (21.7) | 29.8 (25.2) | 4.0 (−7.9–16.0) | 0.17 | 0.112 | | Sum score | 22 | 41.3 (15.7) | 24.2 (16.6) | 17.1 (12.0–22.3) | 1.05 | <0.001 | | Deterioration of symptoms mean (SD) | | | | | | | | F1 Impact of disease | 19 | 27.8 (16.3) | 42.3 (20.8) | 14.5 (20.4–8.5) | −0.77 | <0.001 | | F2 Expectancy | 19 | 44.8 (27.0) | 51.9 (24.8) | 7.1 (13.9–.3) | −0.27 | <0.001 | | F3 Treatment | 19 | 32.5 (22.4) | 44.0 (23.8) | 11.6 (22.3–.9) | −0.49 | 0.017 | | F4 Intimacy | 19 | 25.0 (22.7) | 35.6 (22.2) | 10.5 (21.0–.1) | −0.47 | 0.018 | | F5 Stigma | 19 | 20.1 (16.7) | 33.9 (25.7) | 13.8 (23.1–4.6) | −0.63 | 0.002 | | F6 Complications | 19 | 29.5 (20.0) | 61.7 (21.5) | 32.2 (42.6–21.8) | −1.55 | <0.001 | | Sum score | 19 | 31.7 (17.6) | 42.3 (19.3) | 10.6 (16.7–4.5) | −0.57 | <0.001 |
|
|
Abbreviations: F1–F6: rating form of IBD patient concerns, factors 1–6. V1: baseline, V2: 6-months followup.
|
